<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01886092</url>
  </required_header>
  <id_info>
    <org_study_id>H-1212-081-451</org_study_id>
    <secondary_id>SNUHT1</secondary_id>
    <nct_id>NCT01886092</nct_id>
  </id_info>
  <brief_title>Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus</brief_title>
  <acronym>rTMS</acronym>
  <official_title>Verification of the Usefulness of the Repetitive Transcranial Magnetic Stimulation in the Treatment of Chronic Tinnitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Efficacy of different protocols of transcranial magnetic stimulation for the treatment of
      tinnitus
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex has
      an add-on effect for primary auditory cortex rTMS in improving tinnitus-related distress. The
      investigators aimed to investigate whether rTMS of the dorsolateral prefrontal cortex and
      primary auditory cortex are capable of reducing tinnitus loudness.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Enrolling by invitation</last_known_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">September 2016</completion_date>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of tinnitus severity as measured by the Tinnitus Handicap Inventory (THI)</measure>
    <time_frame>Change from Baseline inTinnitus Handicap Inventory at 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Beck's Depression Inventory (BDI)</measure>
    <time_frame>Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>State-Trait Anxiety Inventory (STAI)</measure>
    <time_frame>Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>Baseline, before and after each intervention, 1, 2 and 3 months after the first intervention</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>visual analogue scale (VAS)</measure>
    <time_frame>Baseline, day 7, day 14, 1, 2 and 3 months after the first intervention</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Tinnitus</condition>
  <arm_group>
    <arm_group_label>Active rTMS1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Combined low frequency frontal and temporal repetitive transcranial magnetic stimulation of left primary auditory cortex and left dorsolateral prefrontal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active rTMS2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Temporal low frequency repetitive transcranial magnetic stimulation of left primary auditory cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active rTMS3</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Frontal low frequency repetitive transcranial magnetic stimulation of left dorsolateral prefrontal cortex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Condition</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Combined low frequency frontal and temporal repetitive transcranial magnetic stimulation of left primary auditory cortex and left dorsolateral prefrontal cortex</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active rTMS 1</intervention_name>
    <description>repetitive transcranial magnetic stimulation (Figured 8-Coil Cool-B65): 1000 stimuli of 1Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) followed by 2000 stimuli of 1 Hz rTMS over the left primary auditory cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects).</description>
    <arm_group_label>Active rTMS1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active rTMS 2</intervention_name>
    <description>repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left temporal cortex (110% motor threshold), each consisting of 4 days of rTMS treatment. (20 subjects)</description>
    <arm_group_label>Active rTMS2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Active rTMS 3</intervention_name>
    <description>repetitive transcranial magnetic stimulation (Figured 8-Coil MCF-B65): 3000 stimuli of 1 Hz rTMS over the left dorsolateral prefrontal cortex (110% motor threshold) each consisting of 4 days of rTMS treatment. (20 subjects)</description>
    <arm_group_label>Active rTMS3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham condition</intervention_name>
    <description>Sham rTMS, applied with the same combination of parameters as active rTMS, except for the number of stimulations per session. (20 subjects)</description>
    <arm_group_label>Sham Condition</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of chronic tinnitus

          -  Chronic subjective tinnitus for more than 6 months

          -  Subject is naive regarding rTMS

          -  Other concurrent treatments: A four-week washout from any other tinnitus treatment or
             management program is required prior to entering this study

          -  Stable enough to complete this study per the opinion of the Study Physician

          -  No restrictions, provided the dosages have been in place for at least 3 months

          -  A three month washout from any other tinnitus treatment or management program is
             required prior to entering this study.

        Exclusion Criteria:

          -  Objective tinnitus or tinnitus with treatable cause

          -  Presence of intracranial or intraocular ferromagnetic materiel or particles

          -  Cardiac pacemaker or other electronic implants (including cochlear implant) Serious
             heart disease or other unstable major medical condition

          -  Personal history of central nervous system disorder, head injury, stroke or seizures

          -  Familial history of epilepsy

          -  Concomitant medication with antidepressants and antipsychotics

          -  Pregnant women

          -  Others known contraindications to rTMS or brain MRI
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Myung-Whan Suh, MD, ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 4, 2013</study_first_submitted>
  <study_first_submitted_qc>June 21, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 25, 2013</study_first_posted>
  <last_update_submitted>October 28, 2015</last_update_submitted>
  <last_update_submitted_qc>October 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tinnitus</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tinnitus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

